Source: FinanzNachrichten

Biological Dynamics: Biological Dynamics, Inc.: Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts

"Lightning talk" session will highlight how the Company's ExoVita Pancreas test can be used to stratify IPMN risk to inform treatment decisions Biological Dynamics, Inc., a leader in exosome enric...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Paul R Billings's photo - CEO of Biological Dynamics

CEO

Paul R Billings

CEO Approval Rating

83/100

Read more